ABBV vs AMZN: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Amazon.com, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-06.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Amazon.com, Inc. · Consumer Cyclical
$242.67
+22.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
AMZN has more upside to fair value
(+22.0%).
AMZN trades at a lower forward P/E
(28.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMZN |
| Current Price |
$261.07 |
$242.67 |
| Fair Value Estimate |
$264.30 |
$295.95 |
| Upside to Fair Value |
+1.2%
|
+22.0%
|
| Market Cap |
$461.3B |
$2,610.4B |
| Forward P/E |
128.0x
|
28.7x
|
| EV / EBITDA |
31.0x
|
14.4x
|
| Price / Sales |
7.3x
|
3.5x
|
| Price / FCF |
22.1x
|
-1056.0x
|
| Revenue Growth YoY |
+12.4%
|
+16.6%
|
| Gross Margin |
70.7%
|
50.6%
|
| Operating Margin |
27.6%
|
11.5%
|
| Return on Equity |
68.0%
|
23.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
—
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Amazon.com, Inc. operates a diversified platform with core engines in retail, AWS cloud services, and advertising, leveraging a strong competitive moat driven by scale, logistics, and technology leadership. The company exhibits high business quality with 23.3% ROE, 16.6% revenue growth, and 76.7% earnings growth in the most recent quarter, supported by a widening moat in e-commerce and cloud. Des…
Accumulation Zones
| Metric |
ABBV |
AMZN |
| Zone Low |
$198.23 |
$221.96 |
| Zone High |
$224.66 |
$251.56 |
| In Buy Zone? |
No
|
Yes
|